Serum NSE is Early Marker of Transformed Neuroendocrine Tumor After EGFR-TKI Treatment of Lung Adenocarcinoma

Serum NSE is Early Marker of Transformed Neuroendocrine Tumor After EGFR-TKI Treatment of Lung Adenocarcinoma

Xiaowei Mao,1,2,* Jiabing Liu,3,* Fang Hu,1,* Yanjie Niu,1 Feng Pan,1 Xiaolong Fu,3 Liyan Jiang1 1Pulmonary and Critical Care Medicine, Shanghai Jiao Tong University, Shanghai Chest Hospital, Shanghai, People’s Republic of China; 2Department of Pulmonary and Critical Care Med...

Full description

Bibliographic Details
Main Authors: Mao X, Liu J, Hu F, Niu Y, Pan F, Fu X, Jiang L
Format: Article
Language:English
Published: Dove Medical Press 2022-03-01
Series:Cancer Management and Research
Subjects:
transformation
egfr-tki
target therapy
lung neuroendocrine tumor
neuron-specific enolase
Online Access:https://www.dovepress.com/serum-nse-is-early-marker-of-transformed-neuroendocrine-tumor-after-eg-peer-reviewed-fulltext-article-CMAR

Internet

https://www.dovepress.com/serum-nse-is-early-marker-of-transformed-neuroendocrine-tumor-after-eg-peer-reviewed-fulltext-article-CMAR

Similar Items